A randomized controlled trial published in Urology (2014) examined the efficacy of tadalafil 5 mg once daily in men with erectile dysfunction (ED) and partial response to on-demand PDE5 inhibitors (PDE5Is), assessing the role of testosterone levels. The study included men aged 18 and older with at least a 3-month
